chemotherapy-induced neuropathy | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 33,801 条关于 “chemotherapy-induced neuropathy”

Akeso's AK135 Shows Promise for Chemotherapy-Induced Neuropathy in Preclinical Studies

Exercise Shows Promise in Managing Chemotherapy-Induced Neuropathy for Ovarian Cancer Patients

Phase III Trial Tests Yoga as Non-Pharmacological Treatment for Chemotherapy-Induced Peripheral Neuropathy

Asahi Kasei Pharma Initiates Phase III Trial of ART-123 for Chemotherapy-Induced Peripheral Neuropathy Prevention

Psilocybin prevents chemotherapy-induced peripheral neuropathy in preclinical models, paving the way for a Phase 2 trial

Topical Drug Combinations Show Promise for Chemotherapy-Induced Peripheral Neuropathy

AlgoTx Completes Phase II Trial of ATX01 for Chemotherapy-Induced Peripheral Neuropathy

Duloxetine Fails to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients

AH-008 Achieves Dual Regulatory Milestones with U.S. FDA IND Clearance and Taiwan CDE Index Case Designation for CIPN Prevention

Octavian Therapeutics Emerges with New Brand and £10M Fundraising Plan for Neuropathic Pain Drug Development

第 1 页，共 599 页